Mor demonstrates the ability to protect neurons and decelerate the progression of Parkinson’s disease (PD). In the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, Mor activates ...

Advanced glycation end products (AGEs) promote JNK phosphorylation and MMP-1 expression via the SIRT1/NF-κB pathway, resulting in collagen ... Furthermore, alpha-synuclein (α-SYN) contributes to ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

For the first time, a molecular mechanism is identified, for experimental acceleration and deceleration (rejuvenation) of sperm epigenetic aging.

Higher exposure to air pollution increases the risk for Parkinson's disease (PD), according to a study published online Sept.

“Molecular pathways activated by low-dose carbon monoxide may slow the onset and limit the pathology in Parkinson’s disease.” These findings led Gomperts and his colleagues to test the effects of low ...

It can be a symptom of Parkinson’s disease. It may occur as dopamine levels fluctuate. Parkinson’s disease affects the nervous system, specifically dopamine neurons in the brain. Some ...

Today, Parkinson’s disease is the second most common neurodegenerative ... Our findings indicate that inhibiting Drp1 from more than one pathway could protect cells from degeneration.

Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...